Advertisement

Topics

Access Pharmaceuticals Company Profile

05:02 EDT 26th September 2017 | BioPortfolio

Access Pharmaceuticals is an emerging biotechnology company focused on the development and commercialization of products using the companies targeted delivery systems to improve clinical outcomes for patients. Together with our subsidiaries we have proprietary patents or rights to a number of drug delivery platforms,Synthetic polymer targeted delivery,Vitamin mediated targeted delivery, Vitamin mediated oral delivery, Bioerodible cross-linker technology, and Hydrogel particle aggregate chnology. The company’s primary development focus is in the area of oncology with its polymer therapeutics program. The company’s lead product, AP5346, is in Phase II clinical development and is a polymer of DACH-platinum, the active principal of oxaliplatin (Eloxatin; sanofiventis).

Location

2600 N. Stemmons Freeway Suite 176
Dallas
75207-2107
United States of America

Contact

Phone: 214 905 5100
Fax: 214 905 5101
Email: akc@accesspharma.com


News Articles [1675 Associated News Articles listed on BioPortfolio]

Deals this week: Pivot Pharmaceuticals, Innovation Pharmaceuticals, Portola Pharmaceuticals

Pivot Pharmaceuticals plans to acquire the worldwide rights to Altum Pharmaceuticals’ BiPhasix Transdermal drug delivery technology.

DMD patients in the UK win early access to Santhera’s Raxone

Santhera Pharmaceuticals’ Raxone has become the first drug for Duchenne Muscular Dystrophy (DMD) to join the UK’s Early Access to Medicines Scheme (EAMS).

Cadence Pharmaceuticals To Present At The 2013 Wedbush PacGrow Life Sciences Management Access Conference On August 13, 2013

SAN DIEGO, Aug. 6, 2013 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product...

Amylin Pharmaceuticals to Present at the Leerink Swann 2012 Global Healthcare Conference

SAN DIEGO, Feb. 9, 2012 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the Leerink Swann 2012 Global Healthcare Conference in New York on Thursday, February 16, 2012...

Santhera Gets First Duchenne Drug OKd Under UK Early Access Scheme

Santhera Pharmaceuticals’ Raxone has become the first treatment for Duchenne muscular dystrophy to be OKd under the UK’s early access...   

Vertex Announces Long-Term Reimbursement Agreement with the Republic of Ireland for ORKAMBI (lumacaftor/ivacaftor), KALYDECO (ivacaftor) and Future Cystic Fibrosis Medicines

-Agreement provides access to ORKAMBI for people who have two copies of the F508del mutation and expands access to KALYDECO for all eligible patients- Vertex Pharmaceuticals Incorporated (Nasdaq:V...

Inotek Pharmaceuticals announces merger deal with Rocket Pharmaceuticals

Inotek Pharmaceuticals announced that it has entered into a definitive merger agreement with US-based gene therapy company Rocket Pharmaceuticals.

Raxone is first to receive positive opinion through the Early Access to Medicines Scheme

Santhera Pharmaceuticals has announced that the MHRA has granted a positive scientific opinion through the Early Access to Medicines Scheme (EAMS) to Raxone (idebenone) for patients with respiratory f...

Drugs and Medications [308 Associated Drugs and Medications listed on BioPortfolio]

Formucare triple antibiotic [Access Business Group International LLC]

Access Business Group International LLC Triple Antibiotic Drug Facts

Fulton street market athletes foot [Access Business Group LLC]

Access Business Group LLC Athlete's Foot Cream Drug Facts

Formu care calcium antacid [Access Business Group LLC]

Access Business Group LLC Calcium Antacid Tablets Drug Facts

Formucare ranitidine [Access Business Group International LLC]

Access Business Group International LLC Ranitidine 75 Drug Facts

Glister multi-action fluoride toothpaste [Access Business Group, LLC]

Glister Multi-action Fluoride Toothpaste

PubMed Articles [1123 Associated PubMed Articles listed on BioPortfolio]

Vascular Access in Pediatric Patients in the Emergency Department: Types of Access, Indications, and Complications.

Vascular access is a potentially life-saving procedure that is a mainstay of emergency medicine practice. There are a number of challenges associated with obtaining and maintaining vascular access, an...

Vascular access in pediatric patients in the emergency department: types of access, indications, and complications digest.

Vascular access is a potentially life-saving procedure that is a mainstay of emergency medicine practice. There are a number of challenges associated with obtaining and maintaining vascular access, an...

Applied Anatomy for Tibial Intraosseous Access in Adults: A Radioanatomical Study.

Intraosseous access is a method for providing vascular access in resuscitation of critically ill and injured patients when traditional intravenous access is difficult or impossible. There is a lack of...

Announcing the 2017 Pharmaceuticals Travel Award for Young Post-Doctoral Researchers.

Last year, for the first time in its history, our Journal was able to offer a travel grant of 800 CHF to a young researcher in the field of medicinal chemistry.

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Clinical Trials [1330 Associated Clinical Trials listed on BioPortfolio]

A Continued Access Protocol to Provide Xolair to Patients With Severe Allergic Asthma

This is a continued access protocol to provide subjects who have completed Genentech, Inc. Study Q2143g, Q2195g, or Q2461g or Novartis Pharmaceuticals Corporation Study CIGE025 0010E1 with...

TMC114-TiDP29-C232 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir (Rtv) for Children Coming From Any of the Three Ongoing Tibotec Sponsored Pediatric Studies With DRV

The primary objective of this study is to continue to provide Darunavir (DRV) to pediatric patients who previously received DRV in any of three pediatric clinical studies sponsored by Tibo...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [2103 Associated Companies listed on BioPortfolio]

Access Pharmaceuticals, Inc.

Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes proprietary products for the treatment and supportive care of cancer patients. Access' products i...

Access Pharmaceuticals

Access Pharmaceuticals is an emerging biotechnology company focused on the development and commercialization of products using the companies targeted delivery systems to improve clinical outcomes for ...

Access Business Group LLC

Welcome to Access Business Group.Whether you need a reliable supplier or extra capacity solutions, count on Access Business Group for high service levels and quick turnaround.Financially stable, the h...

Lif inviterer sammen

Lif’s vision:The value of pharmaceuticals to be visible to Danish society and recognised in a patient-centric public health service the pharmaceutical industry to be perceived as a responsible partn...

NovoBiotic Pharmaceuticals, LLC

NovoBiotic Pharmaceuticals is a privately held, early stage pharmaceutical company focused on the development of novel antibiotics.The Company’s founding scientists, Northeastern University professo...

More Information about "Access Pharmaceuticals" on BioPortfolio

We have published hundreds of Access Pharmaceuticals news stories on BioPortfolio along with dozens of Access Pharmaceuticals Clinical Trials and PubMed Articles about Access Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Access Pharmaceuticals Companies in our database. You can also find out about relevant Access Pharmaceuticals Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record